(Q47803626)

5 February 2018

meta-analysis

0 references

title

Gene expression meta-analysis identifies chromosomal regions involved in ovarian cancer survival (English)

1 reference

5 February 2018

1 reference

4

1 reference

5 February 2018

author name string

Mads Thomassen

1

1 reference

5 February 2018

Kirsten M Jochumsen

2

1 reference

5 February 2018

Ole Mogensen

3

1 reference

5 February 2018

Torben A Kruse

5

1 reference

5 February 2018

publication date

1 August 2009

1 reference

5 February 2018

Genes, Chromosomes and Cancer

published in

1 reference

5 February 2018

volume

48

1 reference

5 February 2018

issue

8

1 reference

5 February 2018

page(s)

711-724

1 reference

5 February 2018

Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours

cites work

1 reference

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer

21 January 2018

1 reference

7 January 2021

High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer

1 reference

7 January 2021

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

1 reference

7 January 2021

Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas

1 reference

7 January 2021

Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact

1 reference

7 January 2021

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

1 reference

7 January 2021

Genomic aberrations and survival in cutaneous T cell lymphomas.

1 reference

7 January 2021

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy

1 reference

7 January 2021

Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas

1 reference

7 January 2021

Spectrum of activity and mechanism of action of VEGF/PDGF inhibitors

1 reference

7 January 2021

DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients

1 reference

7 January 2021

Prognostic value of cytogenetic abnormalities in previously untreated patients with non-Hodgkin's lymphoma

1 reference

7 January 2021

Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67

1 reference

7 January 2021

Plasma thrombopoietin compared with immunoglobulin heavy-chain mutation status as a predictor of survival in chronic lymphocytic leukemia.

1 reference

7 January 2021

Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization.

1 reference

7 January 2021

Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma

1 reference

7 January 2021

Metastatic potential correlates with enzymatic degradation of basement membrane collagen

1 reference

7 January 2021

Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival.

1 reference

7 January 2021

Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer

1 reference

7 January 2021

Cytogenetic analysis of carboplatin resistance in early-stage epithelial ovarian carcinoma

1 reference

7 January 2021

Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage

1 reference

7 January 2021

Karyotypic characteristics of borderline malignant tumors of the ovary: trisomy 12, trisomy 7, and r(1) as nonrandom features

1 reference

7 January 2021

Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome

1 reference

7 January 2021

Chromosome 6p amplification and cancer progression.

1 reference

7 January 2021

Gene expression signature with independent prognostic significance in epithelial ovarian cancer

1 reference

7 January 2021

Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma

1 reference

7 January 2021

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 reference

7 January 2021

Genetic aberrations detected by comparative genomic hybridization predict outcome in patients with endometrioid carcinoma

1 reference

7 January 2021

Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancer

1 reference

7 January 2021

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

1 reference

7 January 2021

Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes

1 reference

7 January 2021

Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2.

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20676

1 reference

5 February 2018

1 reference

5 February 2018